InspireMD (NSPR) Stock Price

InspireMD Price

NYSE AMEX·CLOSED
0.72USD+0.02 (+3.03 %)
Market closed

Over the last 17 years InspireMD grew revenue by 5.9% annually, reaching 8.98 M USD. For InspireMD, the net margin of -543.3% is down versus -331.9% a few years ago. The consensus 12-month price target for InspireMD is 5.10 USD, about 612.0% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 9% above its 52-week low.

InspireMD stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of InspireMD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how InspireMD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing InspireMD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

InspireMD Stock Price History
DateInspireMD Price
7/27/20260.72 USD
7/23/20260.69 USD
7/22/20260.70 USD
7/21/20260.70 USD
7/20/20260.70 USD
7/17/20260.70 USD
7/16/20260.71 USD
7/15/20260.72 USD
7/14/20260.72 USD
7/13/20260.72 USD
7/10/20260.72 USD
7/9/20260.71 USD
7/8/20260.71 USD
7/7/20260.72 USD
7/6/20260.66 USD
7/2/20260.70 USD
7/1/20260.68 USD
6/30/20260.70 USD
6/29/20260.68 USD
6/26/20260.72 USD
6/25/20260.65 USD
6/24/20260.70 USD
6/23/20260.70 USD
6/22/20260.76 USD
6/18/20260.71 USD
6/17/20260.74 USD
6/16/20260.71 USD
6/15/20260.76 USD
6/12/20260.73 USD
6/11/20260.73 USD
6/10/20260.78 USD
6/9/20260.77 USD
6/8/20260.82 USD
6/5/20260.88 USD
6/4/20260.93 USD
6/3/20260.96 USD
6/2/20261.01 USD
6/1/20260.99 USD
5/29/20260.92 USD
5/28/20260.90 USD
5/27/20260.88 USD
5/26/20260.95 USD
5/22/20261.00 USD
5/21/20261.03 USD
5/20/20261.00 USD
5/19/20261.00 USD
5/18/20261.05 USD
5/15/20261.05 USD
5/13/20261.17 USD
5/12/20261.20 USD
5/8/20261.15 USD
5/7/20261.16 USD
5/5/20261.10 USD
5/4/20261.17 USD
4/22/20261.32 USD
4/21/20261.33 USD
4/20/20261.35 USD
4/16/20261.35 USD
4/15/20261.35 USD
4/14/20261.35 USD
4/13/20261.35 USD
4/9/20261.34 USD
4/8/20261.37 USD
4/7/20261.39 USD
4/6/20261.49 USD
4/2/20261.54 USD
4/1/20261.57 USD
3/31/20261.63 USD
3/30/20261.59 USD
3/27/20261.59 USD
3/26/20261.73 USD
3/25/20261.77 USD
3/24/20261.79 USD
3/23/20261.74 USD
3/20/20261.81 USD
3/19/20261.71 USD
3/18/20261.79 USD
3/17/20261.79 USD
3/16/20261.64 USD
3/13/20261.65 USD
3/12/20261.65 USD
3/11/20261.65 USD
3/10/20261.64 USD
3/9/20261.65 USD
3/6/20261.64 USD
3/5/20261.64 USD
3/4/20261.61 USD
3/3/20261.70 USD
3/2/20261.83 USD
2/27/20261.78 USD
2/26/20261.83 USD
2/25/20261.82 USD
2/24/20261.85 USD
2/23/20261.82 USD
2/20/20261.81 USD
2/19/20261.74 USD
2/18/20261.73 USD
2/17/20261.75 USD
2/13/20261.75 USD
2/12/20261.70 USD
2/11/20261.73 USD
2/10/20261.78 USD
2/9/20261.77 USD
2/6/20261.74 USD
2/5/20261.64 USD
2/4/20261.64 USD
2/3/20261.64 USD
2/2/20261.63 USD
1/30/20261.58 USD
1/29/20261.62 USD
1/28/20261.65 USD
1/27/20261.65 USD
1/26/20261.65 USD
1/23/20261.62 USD
1/22/20261.71 USD
1/21/20261.62 USD
1/20/20261.61 USD
1/16/20261.59 USD
1/15/20261.60 USD
1/14/20261.59 USD
1/13/20261.58 USD
1/12/20261.62 USD
1/9/20261.72 USD
1/8/20261.84 USD
1/7/20261.81 USD
1/6/20261.81 USD
1/5/20261.93 USD
1/2/20261.86 USD
12/31/20251.78 USD
12/30/20251.89 USD
12/29/20251.88 USD
12/26/20251.95 USD
12/24/20252.05 USD
12/23/20252.15 USD
12/22/20252.12 USD
12/19/20251.99 USD
12/18/20252.00 USD
12/17/20251.92 USD
12/16/20251.94 USD
12/15/20251.97 USD
12/12/20251.95 USD
12/11/20251.95 USD
12/10/20251.89 USD
12/9/20251.81 USD
12/8/20251.82 USD
12/5/20251.88 USD
12/4/20251.92 USD
12/3/20251.91 USD
12/2/20251.93 USD
12/1/20251.98 USD
11/28/20251.98 USD
11/26/20252.09 USD
11/25/20252.00 USD
11/24/20251.96 USD
11/21/20251.93 USD
11/20/20251.70 USD
11/19/20251.92 USD
11/18/20251.96 USD
11/17/20252.01 USD
11/14/20252.11 USD
11/13/20251.87 USD
11/12/20251.79 USD
11/11/20251.63 USD
11/10/20251.68 USD
11/7/20251.81 USD
11/6/20251.96 USD
11/5/20252.11 USD
11/4/20252.13 USD
11/3/20252.29 USD
10/31/20252.21 USD
10/30/20252.19 USD
10/29/20252.27 USD
10/28/20252.24 USD
10/27/20252.26 USD
10/23/20252.25 USD
10/22/20252.24 USD
10/21/20252.35 USD
10/20/20252.34 USD
10/16/20252.38 USD
10/15/20252.38 USD
10/14/20252.37 USD
10/13/20252.42 USD
10/9/20252.40 USD
10/8/20252.44 USD
10/7/20252.42 USD
10/6/20252.50 USD
10/2/20252.41 USD
10/1/20252.40 USD
9/30/20252.41 USD
9/29/20252.42 USD
9/25/20252.37 USD
9/24/20252.42 USD
9/23/20252.40 USD
9/22/20252.44 USD
9/18/20252.42 USD
9/17/20252.40 USD
9/16/20252.41 USD
9/15/20252.38 USD
9/11/20252.42 USD
9/10/20252.40 USD
9/9/20252.46 USD
9/8/20252.40 USD
9/4/20252.44 USD
9/3/20252.43 USD
9/2/20252.43 USD
8/28/20252.42 USD
8/27/20252.44 USD
8/26/20252.47 USD
8/25/20252.40 USD
8/21/20252.37 USD
8/20/20252.45 USD
8/19/20252.41 USD
8/18/20252.49 USD
8/14/20252.50 USD
8/13/20252.50 USD
8/12/20252.52 USD
8/11/20252.58 USD
8/7/20252.39 USD
8/6/20252.50 USD
8/5/20252.45 USD
8/4/20252.67 USD
7/31/20252.79 USD
7/30/20252.37 USD
7/29/20252.44 USD
7/28/20252.44 USD
Access this data via the Eulerpool API
Get Free API Key

InspireMD Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
2.49 M USD
-10.38 M USD
-10.54 M USD
Jan 1, 2021
4.50 M USD
-14.72 M USD
-14.92 M USD
Jan 1, 2022
5.17 M USD
-18.71 M USD
-18.49 M USD
Jan 1, 2023
6.21 M USD
-21.14 M USD
-19.92 M USD
Jan 1, 2024
7.01 M USD
-33.50 M USD
-32.01 M USD
Jan 1, 2025
8.98 M USD
-49.11 M USD
-48.79 M USD
Jan 1, 2026 (e)
10.38 M USD
-10.38 M USD
-31.03 M USD
Jan 1, 2027 (e)
21.92 M USD
-21.92 M USD
-25.58 M USD

InspireMD Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 28, 2026, 11:47 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
5.004.002.002.001.002.003.003.002.004.005.006.007.008.0010.0021.00
–-20.00-50.00–-50.00100.0050.00–-33.33100.0025.0020.0016.6714.2925.00110.00
40.0050.00100.00100.00200.00100.0066.6766.67100.0050.0020.0016.6714.2925.0025.0025.00
2.002.002.002.002.002.002.002.002.002.001.001.001.002.002.505.25
–-15.00-23.00-14.00-7.00-8.00-7.00-9.00-10.00-14.00-18.00-21.00-33.00-49.00-10.00-21.00
–-375.00-1,150.00-700.00-700.00-400.00-233.33-300.00-500.00-350.00-360.00-350.00-471.43-612.50-100.00-100.00
–-29.00-25.00-15.00-8.00-8.00-7.00-10.00-10.00-14.00-18.00-19.00-32.00-48.00-31.00-25.00
––-13.79-40.00-46.67–-12.5042.86–40.0028.575.5668.4250.00-35.42-19.35
73.470.1473.4773.47––0.060.302.537.808.0424.2748.8973.4773.4773.47
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales InspireMD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue InspireMD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare InspireMD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares InspireMD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against InspireMD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

InspireMD stock margins

The InspireMD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of InspireMD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for InspireMD.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
3.34 %
-417.71 %
-424.31 %
Jan 1, 2021
16.77 %
-327.39 %
-331.88 %
Jan 1, 2022
21.60 %
-361.88 %
-357.59 %
Jan 1, 2023
29.12 %
-340.74 %
-320.97 %
Jan 1, 2024
21.49 %
-478.00 %
-456.63 %
Jan 1, 2025
29.50 %
-546.97 %
-543.33 %
Jan 1, 2026 (e)
29.50 %
-100.00 %
-299.06 %
Jan 1, 2027 (e)
29.50 %
-100.00 %
-116.71 %

InspireMD Stock Revenue, EBIT, Earnings per Share

The InspireMD earnings per share therefore indicates how much revenue InspireMD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.98 USD
-4.10 USD
-4.16 USD
Jan 1, 2021
0.58 USD
-1.89 USD
-1.91 USD
Jan 1, 2022
0.64 USD
-2.33 USD
-2.30 USD
Jan 1, 2023
0.26 USD
-0.87 USD
-0.82 USD
Jan 1, 2024
0.14 USD
-0.69 USD
-0.65 USD
Jan 1, 2025
0.12 USD
-0.67 USD
-0.66 USD
Jan 1, 2026 (e)
0.25 USD
-0.14 USD
-0.74 USD
Jan 1, 2027 (e)
0.52 USD
-0.30 USD
-0.61 USD

InspireMD business model & stock analysis

InspireMD Segments

InspireMD Revenue by Segment

  • 3 Years

  • 5 Years

  • Max

C Guard E P S
CGuard EPS
CGuard™ EPS
CGuardu0099 EPS
CGuard
MGuard Primeu0099 EPS
MGuard
MGuard Prime™ EPS
MGuard Prime EPS
Details
Date
C Guard E P S
CGuard EPS
CGuard™ EPS
CGuardu0099 EPS
CGuard
MGuard Primeu0099 EPS
MGuard
MGuard Prime™ EPS
MGuard Prime EPS
Jan 1, 2016
0.00 USD
0.00 USD
0.00 USD
0.00 USD
1.15 M USD
0.00 USD
747,000.00 USD
0.00 USD
0.00 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
1.92 M USD
0.00 USD
839,000.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
2.97 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
631,000.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
3.27 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
456,000.00 USD
Jan 1, 2020
0.00 USD
2.76 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
-279,000.00 USD
Jan 1, 2021
0.00 USD
4.31 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
186,000.00 USD
Jan 1, 2022
0.00 USD
5.12 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
48,000.00 USD
Jan 1, 2023
6.21 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

InspireMD Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Other Countries
ITALY
GERMANY
RUSSIAN FEDERATION
Russia
Spain
Poland
Belarus
Middle East
Brazil
Details
Date
Other Countries
ITALY
GERMANY
RUSSIAN FEDERATION
Russia
Spain
Poland
Belarus
Middle East
Brazil
Jan 1, 2017
1.31 M USD
557,000.00 USD
551,000.00 USD
0.00 USD
343,000.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
1.76 M USD
632,000.00 USD
855,000.00 USD
0.00 USD
351,000.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
1.67 M USD
686,000.00 USD
727,000.00 USD
0.00 USD
272,000.00 USD
0.00 USD
370,000.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
962,000.00 USD
596,000.00 USD
708,000.00 USD
0.00 USD
0.00 USD
0.00 USD
219,000.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
2.57 M USD
981,000.00 USD
948,000.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
3.34 M USD
970,000.00 USD
866,000.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
3.38 M USD
1.20 M USD
896,000.00 USD
738,000.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
4.15 M USD
1.22 M USD
926,000.00 USD
713,000.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

InspireMD Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

InspireMD historical P/E ratio, EBIT multiple, and P/S ratio

InspireMD annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

InspireMD shares outstanding

The number of shares of InspireMD was 73.47 M in 2025. This indicates how many shares InspireMD is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
2.53 M Stocks
Jan 1, 2021
7.80 M Stocks
Jan 1, 2022
8.04 M Stocks
Jan 1, 2023
24.27 M Stocks
Jan 1, 2024
48.89 M Stocks
Jan 1, 2025
73.47 M Stocks
Jan 1, 2026 (e)
73.47 M Stocks
Jan 1, 2027 (e)
73.47 M Stocks

InspireMD stock splits

In InspireMD's history, there have been no stock splits.

Current InspireMD forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
25.00 %
Buy87.50 % (7)
Hold12.50 % (1)
Sell0.00 % (0)
12M Price Target
5.10
Last Price
0.72
Currency
USD
12M Return Potential
611.99 %
LTM Return
0 %

InspireMD Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/11/2026-0.20USD1.41 MUSD2026 Q2
5/12/2026-0.18USD2.75 MUSD2026 Q1
5/7/2026-0.18USD2.75 MUSD2026 Q1
3/18/2026-0.20USD2.68 MUSD2025 Q4
3/10/2026-0.20USD2.68 MUSD2025 Q4
11/12/2024-0.20USD1.77 MUSD2024 Q3
5/14/2024-0.17USD1.57 MUSD2024 Q1
3/28/2024-0.20USD1.66 MUSD2023 Q4
11/6/2023-0.62USD3.04 MUSD2023 Q3
3/6/2023-0.86USD1.62 MUSD2022 Q4

InspireMD shareholder structure

% Name
9.31527%
Rosalind Advisors, Inc.
Rosalind Advisors, Inc.
8.05298%
Nantahala Capital Management, LLC
Nantahala Capital Management, LLC
7.56853%
abrdn Inc.
abrdn Inc.
7.47323%
OrbiMed Advisors, LLC
OrbiMed Advisors, LLC
5.76344%
Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC
5.37390%
Slosman Marvin
Slosman Marvin
...

InspireMD Executives and Management Board

MS

Mr. Marvin Slosman

(61)

President, Chief Executive Officer, Director · since 2020

Compensation3.30 M USD
SG

Mr. Shane Gleason

(51)

Vice President - Global Marketing, General Manager, North America

Compensation1.52 M USD
AT

Mr. Andrea Tommasoli

(53)

Chief Operating Officer

Compensation359,269.00 USD
PS

Mr. Paul Stuka

(70)

Independent Chairman of the Board

Compensation281,981.00 USD
MB

Mr. Michael Berman

(67)

Independent Director

Compensation182,987.00 USD

InspireMD Supply Chain

Frequently asked questions about InspireMD

Analysts currently set an average price target of 5.10 USD for the InspireMD stock (median: 5.10 USD), implying +612.0 % versus the latest price. The consensus is based on 8 analyst ratings.

InspireMD Analyst Price Targets 2026

All fundamentals and in-depth analysis of InspireMD

Our stock analysis for InspireMD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InspireMD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

InspireMD Stock
InspireMD Revenue→
InspireMD Stock
InspireMD Net Income→
InspireMD Stock
InspireMD P/E→
InspireMD Stock
InspireMD P/S→
InspireMD Stock
InspireMD EBIT→
InspireMD Stock
InspireMD Dividend→
InspireMD Stock
InspireMD Directors Dealings→
InspireMD Stock
InspireMD Stocks→
InspireMD Stock
InspireMD Market capitalization→
InspireMD Stock
InspireMD Debt→
InspireMD Stock
InspireMD Liabilities→
InspireMD Stock
InspireMD Equity→
InspireMD Stock
InspireMD AAQS→
InspireMD Stock
InspireMD Employees→
InspireMD Stock
InspireMD ROE→
InspireMD Stock
InspireMD ROA→
InspireMD Stock
InspireMD ROCE→
InspireMD Stock
InspireMD News→
InspireMD Stock
InspireMD Analyst Price Targets→

Health Stocks

Instituto de DiagnosticoInspire Medical SystemsInsuletInspire IVF PCLIntai TechnologyInspira Technologies Oxy BHNIntco Medical Technology CoInspecs GroupIntech BiopharmInsmedInteger HoldingsInsight Molecular DiagnosticsAll Stocks A–Z →